Evaluating glycolysis-associated biomarkers for radiotherapy sensitivity in head and neck squamous cancer

• by Bilan Xie, Hainan Yang, Chunyuan Lin, Jinzhi Lai

• June 29, 2026

High FCRL5 expression predicts poor treatment response and survival in newly diagnosed multiple myeloma: a retrospective study

• by Cainan Yu, Minghua Zhang, Jie Hui, Mengqing Zhu, Zengtian Sun, Yueyue Sun, Qian Sun, Zhiling Yan, Feng Zhu, Mingshan Niu, Depeng Li, Kunming Qi

• June 29, 2026

ESMO Breast Cancer 2026 Highlights: TRAK-ER

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the TRAK-ER trial, which were presented at the 2026 ESMO Breast Cancer Congress.

• June 26, 2026

• 1 min

Algebraic evaluation of optimization in tumors classification with numerical assessments via a flask–react web interface

• by Nouhaila Houssa, Seddik Abdelalim, Ilias Elmouki

• June 26, 2026